Coronary plaque burden predicts perioperative cardiovascular events after coronary endarterectomy

Mingxin Gao1, Wanwan Wen2,3, Chengxiong Gu1

  • 1Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.

Insights

Maximal coronary plaque length is a significant predictor of perioperative myocardial infarction after coronary artery bypass grafting with endarterectomy. This finding may help identify patients at higher risk for cardiovascular events.

Area of Science:

  • Cardiovascular Surgery
  • Interventional Cardiology
  • Biomarkers

Background:

  • Risk factors for cardiovascular events after coronary artery bypass grafting (CABG) with coronary endarterectomy (CE) are not well understood.
  • Predicting perioperative cardiovascular events in patients undergoing off-pump CABG + CE requires further investigation.

Purpose of the Study:

  • To evaluate the clinical value of coronary plaque burden, coronary anatomic stenosis, and serum biomarkers in predicting perioperative cardiovascular events after off-pump CABG + CE.
  • To identify predictors of perioperative myocardial infarction (PMI) in patients undergoing off-pump CABG + CE.

Main Methods:

  • Retrospective cohort study of 125 patients undergoing off-pump CABG + CE.
  • Coronary plaque burden quantified by plaque length-max (maximum plaque length removed by CE).
  • Primary endpoint was perioperative myocardial infarction (PMI).

Main Results:

  • Plaque length-max was significantly higher in patients with PMI (2.4 ± 1.5 cm) compared to those without (1.6 ± 0.9 cm).
  • A plaque length-max threshold of 1.15 cm independently predicted PMI (AUC: 0.67, sensitivity: 87.9%, specificity: 59.8%).
  • Patients with plaque length-max ≥ 1.15 cm had over a 5-fold increased risk of PMI (OR: 5.89).
  • Interleukin-6, CD68, and osteopontin levels correlated with plaque length-max.

Conclusions:

  • Maximal coronary plaque length (plaque length-max) is a superior predictor of PMI compared to traditional cardiovascular risk factors after off-pump CABG + CE.
  • Elevated plaque length-max may indicate a heightened systemic and plaque inflammation state, contributing to PMI risk.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
28
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
11
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
25
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
14
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
42
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
15